BackAnixa Biosciences Overview

Anixa Biosciences Long Term Debt

Track Anixa Biosciences's long-term debt ($140K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$140000.00
23.91% YoYΔ $-44000.00 vs prior year quarter

Peer average

Loading

Anixa Biosciences Long Term Debt History

Loading

Anixa Biosciences vs. peers: Long Term Debt Comparison

Loading

Anixa Biosciences Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anixa Biosciences (ANIX) FAQ

As of the most recent data (April 2026), ANIX shows a long-term debt of $140K. That compares with $180K in the prior-year period — down 23.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANIX's long-term debt is now $140K (was $180K) — a 23.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Anixa Biosciences is outperforming or lagging.

Tracking ANIX's long-term debt over time shows whether Anixa Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $140K That compares with $180K in the prior-year period — down 23.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Anixa Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $140K) with ownership activity and broader fundamentals.

Anixa Biosciences's long-term debt is $140K; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.